Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Apparently none of you crying have never started a business from the go . They are super money Pitts and if lucky you get a good return year after year. But without a sell out hardly ever get the original nut back.
As a shareholder I put in money as well will vdrm give me some money as well
It would be great if the IR guy would actually answer anything but instead they all hide behind their keyboards.
Doc is making childrens books now.
Nupelo update? India sales update? Egypt? Caribbean? Dubai? USA? NOTHING!
Sounds like the Doc got religion and realized that he was too greedy with the $700K "loan". Where are the specific details on why employees are needed? Expansion of international sales is way too vague. Is demand for the product so extreme that it warrants the new hires? If that were the case, the Doc would scream that from the rooftops. What will the sales team be doing? Will there be specific territories? Specific targeted markets? Ramp-up sales projections? Projected timelines for shipping? IMHO, there are no specifics because they don't exist; once again someone is being fast and lose with the verbage in the PR. What the Doc probably means is that his wife and kids are going on the payroll to make back some of the $700K.
Someone please tell us what "really good" news coming.
Totally agree, with one addition.
If CEO is owed this money, why has there never been recorded liability on Balance Sheet (past years or current), as would be required? For precedent, see previous 100M shares for legitimate $118K principal and interest, where CEO takes care of himself in orders of magnitude of excessiveness.
When is the next quarterly due. Then we will see if:
1. The loan is really paid back and there is really a million dollars in the coffers.
2. There is any inventory.
3. There is any monies from licensing.
4. There is any payroll expenses.
Remember the time he touted that he was hiring field reps to go out and promote product sales … no employees appeared ???
Also Dr. O just took the loan out because of his own payouts for the company expenses and now almost immediately pays the money back. If the loan was to replace person money invested into business expenses then why the repayment at all. Things that make you go hmmmmm 🤔
No mention of the March overseas shipments..SCAM
something big is on its way, saudi Arab country trip, let s see the orders
Hope it is all true, but it all seems so familiar. Hope I'm wrong but I'm calling BULLSHIT! Just my opinion.
Big TBD. Did otiko replace Garrett Adams? He's been the President there for several years and doesn't seem to have ever closed one contract.
Still no mention about Nupelo either. Or ALL those 200,000+ vitastem shipments to India and all the other countries they put in PRs and tweets.
The GOOD from the news:
1) Sales personnel (when actually hired): CEO has more than half a decade of not closing much ballyhooed, game-changing "deals". Also, it reduces the risk to shareholders of the ~30%, undeserved, over-the-top "bonus" to CEO, for just doing his job, (if he ever brought a deal to company that actually went through).
2) Repayment of $700K personal loan
The UNBELIEVABLE in today's news:
The explanation of the personal loan: If CEO had provided resources to company, the resources should have been recorded as liability on Balance Sheet, but are not. The beyond-over-the-top evidence of more than taking care of his interests is March 28, 2023 issue of 100M shares (6.5% of company) to himself, valued at $2.67M at the time, for legitimate principal and interest of $118K (22.5 times the value). Maybe, he perused the charts on X and comprehended the warranted bad look of the facts of the "noteworthy" achievements of recent years.
GOING FORWARD:
1) CEO needs to ensure currentness and accuracy of financial reports (in Section 4) et al, removal of out of date information from past failures) for credibility, to fulfill responsibility to shareholders, and also look like he actually has read the report before signing off on its so called "accuracy", his legal responsibility.
2) Bring Sales personnel on board, who are successful (i.e., raising sales from hundreds of $, to hundreds of thousands of $, and millions of $).
3) Put out credible, accurate, timing and traceable information for shareholders and potential speculators/investors. Note: Still waiting for and chasing answer to growing discrepancy on "official" PR information on state licensing and "official" financial reports revenue recorded. Tomorrow will be two weeks.
Like always with CEO, we'll will see, or not see, as the case may be.
Needed short term cash, returned .!! Put the cash back to move to this company to a new level. If he gets there l for one think that is great for everyone including himself.
So old sloppy why one earth would he need to give himself a loan to pay bills? Why doesn't he just pay the bills right from vdrm account????? Still a scam...and I really doubt he will hire anyone
Great you sold. More for us. See ya :)
So I guess we just have to take the Dr’s word on this😂🤡😂🤡😂🤡
Thought they were already shipping internationally in March? Why are they not doing anything for US sales? Why do they have no sales at all still???
Well selling out might of been a great move for you ,,BUT NOT TO RENTER AT THESE PRICES JUST PLAIN FOOLISHNESS.
I Truly don't believe this is the full truth. The good old doctor has a way of robbing Peter to pay Paul. I sold out some time ago and this still does not convince me to buy back in, even at these prices.
IMHO
I gotta tell you, this news changed it all. I hope he is not Bs as usual. This news really is a good deal, you are right
Another biggie loan repaid heck that alone should easily get us out of this sub penny bull.
I know I am very very happy with this news. One or two overseas orders and we are sailing. Hard to believe that new people would have to start right at the beginning. Perhaps there are already pokers in the fire and these new people are there to finish closing up deals in limbo. Still see great things ahead.
good news out but wait for the great news to come!!
It is going to get worse if his book Santa doesn’t provide him results
Wait wait wait a second……… WTF the Nigerian Vampire is doing writing books about SANTA? It reminds me this MF HPIL-CEO Stephen Brown that end up making silly app gaming CALLED: “GET SANTA”…. 🤣 😂 😜
The company is in CE now and under court battle. But get Santa was the sign of his failures. He was diluting the heck out of investors into stupid game apps etc. Same thing with HMBL
BUT THE DOC, $HIT, a book? Not about medicine? About SANTA? 🤣 I am telling you, when you are consuming Acid, hahahahhahahaha
Forget about Bambi, the question to ask is: Where Is ORCA?
Doc slings BS with every word, there is no inventory, no sales and the price is is the toilet but Deernuts says he's fine with his investment. That's all that matters!
Did he say how soon? Days, weeks, months?
Where is Bambi? He is a big supporter of the Doc, maybe he has been off reading one of the Doc's books. He hasn't been around for a while spreading his falsehoods. But what about his resume and all his investor experience. What about all the conversations with HR? This is and has been circling the drain for a long time now. I was hoping for another BS PR so I can get rid of my remaining shares. Oh well!
Seems the ‘bashers’were on to something
But but but....Mr. Sloppy says soon
...like he has for years. 😂 😢
Peeps finally realizing something isn't right.......it's only been pointed out dozens of times.
Just like Otiko is as a novelist.
https://www.amazon.com/stores/Christopher-Otiko/author/B00N1B4AZ6
https://www.amazon.com/stores/author/B00N1B4AZ6/about
He's playing around writing books now and doesn't care about the company. Wonder where that $700k personal loan went to?
Oof. Almost 900k dumped at .00511. This thing is toast
I think someone is full of shit both here on this board and with IR and Dr O……
the doc never replies so something must be going on! and why would he get all the filings up to date and spend that money and time if something was going on?
Look I get it but you have to admit it is possible he is saying the truth. There was another dude in here whom the friend of his friend gave him accurate intel over the pink update fillings. That dude genuinely was getting contact with the inside. Maybe this guy really got replies. You never know! I want him to be right
The product is real and you know it. I think it is a matter of time for this to fly high enough to let a few of us GTFO
You forgot the $700K and previous forgiven loan he got. Did he smoke it ? Go go bars? Gambling ?? Where did the money go and we will get it back?
That’s his due date, he will do something silly like ORCA. He will get sooo high… Hopefully he doesn’t end up in the E.R. Viva VDRM
I sent them your questions. We are all very interested to read their responses.
excelsiorvision You expect answers from Salsaman?
What happened to the international recognition? You know, all those huge distribution deals to Egypt, India, etc where they were supposed to be shipping to back in March? VA deals? Large HMO deals? Dubai? Nupelo?
It has been frustrating to say the least. We know how great the product is and I believe it will get the national recognition it deserves. We are hoping to have some good news out soon. Please stay tuned,
Rich
Thanks for being a loyal investor, there will be positive news coming very soon.
Dr.Chris Otiko
Two questions- First I thought you mentioned that your emails got rejected?
Second - would you be as so kind to share the actual responses removing your email name of course?
Followers
|
617
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
74420
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.
A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.
The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.
Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.
In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.
We are developing products in the following fields of use;
Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.
Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.
Treats symptoms of Influenza which is a$4B/ year global market: Common
Diabetic foot wounds.
Per 3/8/18 PR: ViaDerma’s technology is currently being used in Elixr Cannabis products; Topical Balm, Topical Serum and Topical Spray. Sales have begun in Canada.
Per 12/7/17 PR: The Company has signed an MOU and will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinary uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments.
Per 1/23/18 PR: The Company has also a licensing and distribution agreement in place with its Canadian partners to produce a CBD Topical Serum, which has a 92% absorption rate powered by ViaDerma's Patent Pending Dual Carrier Technology. The CBD and Terpene profile (enriched with specific essential oils and vitamins C, and D) is crafted to alleviate Chronic Dry Skin, Psoriasis, Eczema, Rosacea, and many other skin conditions. The serum has anti-inflammatory, anti-bacterial, and chronic pain relief properties that are absorbed by the skin and provide overall healing benefits. Sales are expected to begin in the first quarter of 2018 and are projected to generate approximately $2 million annual revenues.
The Patented Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.
CBD is a compound found in the Cannabis family of plants such as hemp. CBD is combined into our topical body care products like Elixr's Topical Balm, Serum, and Spray.
CBD is an antioxidant. Antioxidants protect our skin from damaging exposure to smoke, UV rays, and environmental pollutants. Cannabinoid receptors are located all throughout the skin, Topical CBD products interact with those receptors resulting homeostasis and healing. Studies show that CBD can help treat an array of skin conditions such as eczema, psoriasis, rosacea, and acne.
"What is Intellectual Property?" - A Publication by the World Intellectual Property Organization -
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |